Robotic Telesurgery in Urology

Withdrawn before enrolling · Not applicable

Conditions studied: Prostate Cancer

In brief

The goal of this clinical trial is to confirm the safety and feasibility of robotic telesurgery when used for the surgical management of prostate cancer in participates undergoing treatment for prostate cancer. In this clinical trial, participants will receive robotic telesurgery treatment for prostate cancer.

Key facts

Study ID

NCT07541066

Run by

Case Comprehensive Cancer Center

People needed

0

Starts

2026-05-01

Expected to finish

2027-03-01

Last updated by the study team

2026-04-21

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Adult participants, aged 18 years or older
• Participant has been indicated for a focal therapy treatment for prostate cancer, radical prostatectomy, or partial nephrectomy robotic procedures
• Each participant should fit the clinical criteria to undergo robotic radical procedure, using either the Single Port or Multi Port robotic approaches, laparoscopic, or an open surgical procedure
• Each participant should be willing to participate and consent to participate, as documented by a signed informed consent form

You may not qualify if…

• Participants for which minimally invasive surgery is contraindicated as determined by the investigator
• Participants with comorbidities or medical characteristics, which would preclude the surgical procedure or the equivalent alternative in the opinion of the investigator
• Participants who have been diagnosed with a bleeding disorder and/or cannot be removed from their anticoagulants prior to surgery based on surgeon discretion and standard of care
• Non-oncology participants with an estimated life expectancy of less than 6 months
• Female participants pregnant at the time of the surgical procedure
• Participants who are considered to be part of a vulnerable population, including but not limited to those without sufficient mental capacity
• Participants who have participated in an investigational drug or device research study within 30 days of enrollment that would interfere with this study
• Participants with active infection including but not limited to pneumonia, urinary tract, cellulitis, or bacteremia

Where it is running

• Case Comprehensive Cancer Center, Cleveland Clinic Foundation Glickman Urological Institute — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.